Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics designed to promote healing and regenerative repair of injured tissue, announced today that on June 30, ...

BioLab Holdings, Inc. recently announced the launch of a multicenter hybrid platform trial evaluating the clinical real-world ...

Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore ...

Diabetic foot ulcer recurrence may now be more predictable due to a study that identifies compromised skin barrier function ...

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in ...